Participation of P450 3A enzymes in rat hepatic microsomal retinoic acid 4-hydroxylation.
Cytochrome P450-mediated 4-hydroxylation is an important pathway in the termination of the biological action of retinoids. Several purified mammalian hepatic P450s have been shown to catalyze the 4-hydroxylation of all-trans-retinoic acid (retinoic acid) in reconstituted enzyme systems, but the nature of the activity in untreated rat liver microsomes has not been defined. In the present study, microsomal retinoic acid 4-hydroxylation was characterized in untreated liver from rats of both sexes and after a series of induction treatments. Thus, dexamethasone and phenobarbital, but not beta-naphthoflavone or dimethyl sulfoxide, increased the activity in male and female rats. An immunoglobulin G (IgG) fraction raised against P450 3A1 decreased the rate of retinoic acid 4-hydroxylation in untreated rat hepatic microsomes, but IgG directed against the P450s 2C11, 2B1, and 2C6 were noninhibitory. In vivo administration of triacetyloleandomycin, which has been shown to form a metabolite intermediate complex with P450 3A, followed by potassium ferricyanide oxidation in vitro, reactivated retinoic acid 4-hydroxylation and androst-4-ene-3,17-dione 6 beta-hydroxylation similarly (to 154 and 152% of the respective activities in the absence of potassium ferricyanide). Finally, exogenous retinoic acid (60 mg/kg ip for three days) markedly increased the rate of retinoic acid 4-hydroxylation in hepatic microsomes from male and female rats (3.8- and 3.7-fold, respectively). This occurred without comparable increases in other P450 activities. Despite these findings, the age- and sex-related profiles of microsomal retinoic acid 4-hydroxylation were clearly different from those measured for other P450 activities. Thus, on the basis of xenobiotic pretreatment, developmental, and immunochemical studies, the enzyme(s) involved in constitutive retinoic acid 4-hydroxylation appears distinct from a number of well-described P450s in untreated and induced rat liver. The data are consistent with the partial involvement of P450(s) from the 3A subfamily in retinoic acid 4-hydroxylation, but it seems clear that P450s 3A1 and 3A2 do not participate in this activity.
Martini
R
R
Department of Medicine, University of Sydney, Westmead Hospital, NSW, Australia.
Murray
M
M
D000367:Age Factors; D000735:Androstenedione / Q000378:metabolism; D000818:Animals; D001189:Aryl Hydrocarbon Hydroxylases; D051544:Cytochrome P-450 CYP3A; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D005260:Female; D006900:Hydroxylation; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology*; D010089:Oxidoreductases, N-Demethylating / Q000037:antagonists & inhibitors / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D014212:Tretinoin / Q000008:administration & dosage / Q000378:metabolism*; D014217:Troleandomycin / Q000494:pharmacology
D065607:Cytochrome P-450 Enzyme Inhibitors; D000735:Androstenedione; D014212:Tretinoin; D003577:Cytochrome P-450 Enzyme System; D014217:Troleandomycin; D001189:Aryl Hydrocarbon Hydroxylases; D051544:Cytochrome P-450 CYP3A; D010089:Oxidoreductases, N-Demethylating